May I suggest not to think too much about the expected FDA...

May I suggest not to think too much about the expected FDA announcement, first IHL can not control the date, FDA said they will “ try” by this date.

this is not an FDA approval as I read from some here, it will mainly provide guidance only.

the main catalyst is the US listing which is expected some time in the next 6 months more or less. The recent price jump is a bonus.

drug development needs time and it will not happen overnight, the beautiful thing about this stock is it generally does not drop back due to the patience and understanding of long term holders, for new comers it is good to clarify.